COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier

This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID‐19‐HTLV‐1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.

[1]  S. Demeret,et al.  Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU , 2020, American journal of respiratory and critical care medicine.

[2]  M. Netea,et al.  COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions? , 2020, Journal of fungi.

[3]  Y. Ohe,et al.  COVID-19 pneumonia in a patient with adult T-cell leukemia-lymphoma , 2020, Journal of clinical and experimental hematopathology : JCEH.

[4]  J. Tadié,et al.  Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients , 2020, Critical Care.

[5]  F. Martin,et al.  Human T leukaemia Type 1 and COVID-19 , 2020, Pathogens.

[6]  W. Lim,et al.  Co-infections in people with COVID-19: a systematic review and meta-analysis , 2020, Journal of Infection.

[7]  Lanjuan Li,et al.  Analysis of Epidemiological and Clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Wenjie Yang,et al.  Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China , 2020, Journal of Infection.

[9]  B. Custer,et al.  A retrospective analysis of false‐positive infectious screening results in blood donors , 2016, Transfusion.

[10]  J. Hiscott,et al.  Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis. , 2011, Cytokine & growth factor reviews.

[11]  Anne-Mieke Vandamme,et al.  Human T-lymphotropic virus 1: recent knowledge about an ancient infection. , 2007, The Lancet. Infectious diseases.

[12]  K. Tsao,et al.  False positive antibody results against human T‐cell lymphotropic virus in patients with severe acute respiratory syndrome , 2005, Journal of medical virology.

[13]  M. Matsuoka,et al.  Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. , 2001, Blood.